Hillstream Biopharma Learn more We aim to improve the lives of patients with rare cancers

About Hillstream Biopharma Inc.

Hillstream Biopharma is a clinical stage biotechnology company leveraging its computational intelligence platform to help identify and develop novel therapeutics for rare cancers. The Company is advancing lead candidates, including novel small molecules and proprietary DNA expression vectors which encode inflammatory cytokines directly into the tumor microenvironment. We will work to improve the lives of patients as we rapidly move into the clinic to treat osteosarcoma, small cell lung cancer and other high unmet need rare cancers.

Our Pipeline

HSB-1216: an enhanced injectable suspension of a long-acting ferroptosis inducer for small cell lung cancer

HSB-114: tumor-guided TNF-a DNA via non-viral vector enhanced injectable for soft tissue sarcoma

HSB-720: novel IO agent delivering tumor-targeted IL-2 DNA to solid tumors

Subscribe to Receive Hillstream Biopharma News and Updates By Email